# Allegheny Health Network

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/allegheny-health-network/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 37.7 |
| Citations | 208,798 |
| City | Pittsburgh |
| Country | US |
| Description | Allegheny Health Network is a research organisation in Pittsburgh, US. OpenAlex records 6,690 works and 208,798 citations for it. 2,696 researchers list it as their most recent affiliation. |
| Homepage | https://www.ahn.org/ |
| OpenAlex ID | https://openalex.org/I1310421338 |
| Researchers | 2,696 |
| ROR ID | https://ror.org/0101kry21 |
| Type | healthcare |
| Wikidata ID | https://www.wikidata.org/wiki/Q7986183 |
| Works | 6,690 |

## University papers

Showing 12 of 91.

- [Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/derivation-and-validation-of-the-systemic-lupus-international-collaborating/)
- [Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.](https://scholariq.org/papers/rituximab-chimeric-anti-cd20-monoclonal-antibody-therapy-for-relapsed-indolent/)
- [A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension](https://scholariq.org/papers/a-comparison-of-continuous-intravenous-epoprostenol-prostacyclin-with/)
- [Continuous Intravenous Epoprostenol for Pulmonary Hypertension Due to the Scleroderma Spectrum of Disease](https://scholariq.org/papers/continuous-intravenous-epoprostenol-for-pulmonary-hypertension-due-to-the/)
- [Association of Systemic Lupus Erythematosus with <i>C8orf13–BLK</i> and <i>ITGAM–ITGAX</i>](https://scholariq.org/papers/association-of-systemic-lupus-erythematosus-with-i-c8orf13-blk-i-and-i-itgam/)
- [A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus](https://scholariq.org/papers/a-large-scale-replication-study-identifies-tnip1-prdm1-jazf1-uhrf1bp1-and-il10/)
- [The Effect of Combined Estrogen and Progesterone Hormone Replacement Therapy on Disease Activity in Systemic Lupus Erythematosus: A Randomized Trial](https://scholariq.org/papers/the-effect-of-combined-estrogen-and-progesterone-hormone-replacement-therapy-on/)
- [The frequency and outcome of lupus nephritis: results from an international inception cohort study](https://scholariq.org/papers/the-frequency-and-outcome-of-lupus-nephritis-results-from-an-international/)
- [Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension](https://scholariq.org/papers/randomized-study-of-adding-inhaled-iloprost-to-existing-bosentan-in-pulmonary/)
- [Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases](https://scholariq.org/papers/amphotericin-b-lipid-complex-for-invasive-fungal-infections-analysis-of-safety/)
- [A short course of BG9588 (anti–CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis](https://scholariq.org/papers/a-short-course-of-bg9588-anti-cd40-ligand-antibody-improves-serologic-activity/)
- [Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort](https://scholariq.org/papers/factors-associated-with-damage-accrual-in-patients-with-systemic-lupus/)

## University researchers

- [Srinivas Murali](https://scholariq.org/researchers/srinivas-murali/)
- [John Lister](https://scholariq.org/researchers/john-lister/)
- [Jestin N. Carlson](https://scholariq.org/researchers/jestin-n-carlson/)
- [Katrin Schwameis](https://scholariq.org/researchers/katrin-schwameis/)
- [Sergio A. Sánchez‐Luna](https://scholariq.org/researchers/sergio-a-sanchez-luna/)
- [Daniel Gagné](https://scholariq.org/researchers/daniel-gagne/)
- [Ethan M. Cohen](https://scholariq.org/researchers/ethan-m-cohen/)

## University top topics

Showing 8 of 25.

- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cardiac Arrest and Resuscitation](https://scholariq.org/topics/cardiac-arrest-and-resuscitation/)
- [Esophageal and GI Pathology](https://scholariq.org/topics/esophageal-and-gi-pathology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.